RSLV-145

N/A

Report date: 2024/07/12 15:58:47

First In Class

Base Information

Drug NameRSLV-145

Drug Alias NameRSLV-145

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionDeoxyribonucleases replacementsRibonucleases replacements

TargetsDeoxyribonucleasesRibonucleases

Therapy Area/IndicationsAutoimmune DiseasesLupus Erythematosus, SystemicVasculitis +[5]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesResolve Therapeutics LLC

China Registration ClassN/A

Develop Information

Active CompaniesResolve Therapeutics LLC

Inactive CompaniesN/A

Active IndicationsAutoimmune DiseasesLupus Erythematosus, SystemicVasculitis +[5]

Inactive IndicationsN/A

Other Information

ATC CodeN/A